PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25524556-15	2015	We found that 247 Val was correlated with anti-beta2-GPI production in patients with primary APS, and 247 Val may be important for beta2-GPI antigenicity.	Valine	18-21	apolipoprotein H	Homo sapiens	47-56	
25524556-15	2015	We found that 247 Val was correlated with anti-beta2-GPI production in patients with primary APS, and 247 Val may be important for beta2-GPI antigenicity.	Valine	106-109	apolipoprotein H	Homo sapiens	131-140	
22399073-6	2012	Furthermore, a direct comparison between thrombosis-positive and -negative patients also indicated that the Val/Val + Val/Leu and the Val/Val vs. Leu/Leu genotypes of the beta(2)GPI polymorphism were significantly elevated in patients with thrombosis (OR 2.817, 95% CI 1.200-6.610, p = 0.017; OR 3.312, 95% CI 1.338-8.200, p = 0.010, respectively).	Valine	108-111	apolipoprotein H	Homo sapiens	171-181	
15641049-1	2005	OBJECTIVE: To clarify the consequences of the valine/leucine polymorphism at position 247 of the beta(2)-glycoprotein I (beta(2)GPI) gene in patients with antiphospholipid syndrome (APS), by investigating the correlation between genotypes and the presence of anti-beta(2)GPI antibody.	Valine	46-52	apolipoprotein H	Homo sapiens	121-131	
16686261-2	2006	It has been suggested that the common beta2GPI Valine/Leucine247 (Val/Leu247) polymorphism could be found more commonly in APS and might influence the generation of anti-beta2GPI antibodies.	Valine	47-53	apolipoprotein H	Homo sapiens	38-46	
16686261-2	2006	It has been suggested that the common beta2GPI Valine/Leucine247 (Val/Leu247) polymorphism could be found more commonly in APS and might influence the generation of anti-beta2GPI antibodies.	Valine	47-53	apolipoprotein H	Homo sapiens	170-178	
16686261-2	2006	It has been suggested that the common beta2GPI Valine/Leucine247 (Val/Leu247) polymorphism could be found more commonly in APS and might influence the generation of anti-beta2GPI antibodies.	Valine	47-50	apolipoprotein H	Homo sapiens	38-46	
16686261-2	2006	It has been suggested that the common beta2GPI Valine/Leucine247 (Val/Leu247) polymorphism could be found more commonly in APS and might influence the generation of anti-beta2GPI antibodies.	Valine	47-50	apolipoprotein H	Homo sapiens	170-178	
16686261-3	2006	Therefore we studied beta2GPI Val/Leu247 single-nucleotide polymorphism (SNP) by PCR in 338 patients with various autoimmune diseases (46 with secondary and 84 with primary APS) and 147 sex and age-matched healthy controls.	Valine	30-33	apolipoprotein H	Homo sapiens	21-29	
19758193-2	2009	The objectives of this study were to determine a Val/Leu SNP at position 247 of the beta2-GPI gene in Brazilian patients with APS and to compare these data with clinical and laboratory manifestations.	Valine	49-52	apolipoprotein H	Homo sapiens	84-93	
18777117-0	2009	Association between Val/Leu(247) polymorphism of apolipoprotein H and cerebral infarction in a Chinese population.	Valine	20-23	apolipoprotein H	Homo sapiens	49-65	
18777117-7	2009	RESULTS: Our results demonstrated an association between the Val/Leu(247) polymorphism of apoH gene and aPL in CI patients.	Valine	61-64	apolipoprotein H	Homo sapiens	90-94	
16038107-5	2005	Our results demonstrate an association between substitution of Val for Leu at AA247 (L247V) of beta2GPI and both the development of aPL (P = 0.05) and aPL-associated clinical manifestations (P = 0.03) among pediatric patients.	Valine	63-66	apolipoprotein H	Homo sapiens	95-103	
15641049-7	2005	RESULTS: A positive correlation between the Val(247) allele and the presence of anti-beta(2)GPI antibodies was observed in the patient group.	Valine	44-47	apolipoprotein H	Homo sapiens	85-95	
10446865-1	1999	OBJECTIVE: To determine the frequencies at which either a valine or leucine occurs at position 247 in the beta2-glycoprotein I (beta2GPI) gene of normal individuals of the Caucasian, African American, and Asian ethnic groups and to compare these data with those in patients with the antiphospholipid syndrome (APS), with and without anti-beta2GPI antibodies.	Valine	58-64	apolipoprotein H	Homo sapiens	128-136	
10501418-10	1999	In conclusion, the beta2GPI polymorphism, valine/leucine247, is correlated with anti-beta2GPI antibody production in patients with primary APS, and valine247 may be important in the formation of beta2GPI antigenicity.	Valine	42-48	apolipoprotein H	Homo sapiens	19-27	
10501418-10	1999	In conclusion, the beta2GPI polymorphism, valine/leucine247, is correlated with anti-beta2GPI antibody production in patients with primary APS, and valine247 may be important in the formation of beta2GPI antigenicity.	Valine	42-48	apolipoprotein H	Homo sapiens	85-93	
10501418-10	1999	In conclusion, the beta2GPI polymorphism, valine/leucine247, is correlated with anti-beta2GPI antibody production in patients with primary APS, and valine247 may be important in the formation of beta2GPI antigenicity.	Valine	42-48	apolipoprotein H	Homo sapiens	85-93